These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 15001829)

  • 1. Managing gastro-oesophageal reflux disease in children.
    Cezard JP
    Digestion; 2004; 69 Suppl 1():3-8. PubMed ID: 15001829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological treatment of children with gastro-oesophageal reflux.
    Tighe M; Afzal NA; Bevan A; Hayen A; Munro A; Beattie RM
    Cochrane Database Syst Rev; 2014 Nov; 2014(11):CD008550. PubMed ID: 25419906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic optimisation in the treatment of gastro-oesophageal reflux disease.
    Hatlebakk JG; Berstad A
    Clin Pharmacokinet; 1996 Nov; 31(5):386-406. PubMed ID: 9118586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological treatment of gastro-oesophageal reflux in children.
    Tighe MP; Andrews E; Liddicoat I; Afzal NA; Hayen A; Beattie RM
    Cochrane Database Syst Rev; 2023 Aug; 8(8):CD008550. PubMed ID: 37635269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The diagnosis and management of gastro-oesophageal reflux in infants.
    Vandenplas Y; Salvatore S; Hauser B
    Early Hum Dev; 2005 Dec; 81(12):1011-24. PubMed ID: 16278060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Managing gastro-oesophageal reflux in infants.
    Drug Ther Bull; 2009 Dec; 47(12):134-7. PubMed ID: 20009040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of rabeprazole on early symptom relief in gastro-oesophageal reflux disease: the Hellenic Rabeprazole Study Group surveillance study.
    Archimandritis AJ; Nikolopoulou V; Kouklakis G; Paraskevas E; Avgerinos A; Tsianos E; Triantafillidis JK;
    Curr Med Res Opin; 2005 Apr; 21(4):603-10. PubMed ID: 15899110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proton pump inhibitors or surgery for gastro-oesophageal reflux disease.
    Hinder RA
    Dig Liver Dis; 2002 Feb; 34(2):95-6. PubMed ID: 11926565
    [No Abstract]   [Full Text] [Related]  

  • 9. Laparoscopic fundoplication versus lansoprazole for gastro-oesophageal reflux disease. A pH-metric comparison.
    Frazzoni M; Grisendi A; Lanzani A; Melotti G; De Micheli E
    Dig Liver Dis; 2002 Feb; 34(2):99-104. PubMed ID: 11926567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acid suppression does not change respiratory symptoms in children with asthma and gastro-oesophageal reflux disease.
    Størdal K; Johannesdottir GB; Bentsen BS; Knudsen PK; Carlsen KC; Closs O; Handeland M; Holm HK; Sandvik L
    Arch Dis Child; 2005 Sep; 90(9):956-60. PubMed ID: 16113133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lansoprazole: in the treatment of gastro-oesophageal reflux disease in children and adolescents.
    Croom KF; Scott LJ
    Drugs; 2005; 65(15):2129-35; discussion 2136-7. PubMed ID: 16225368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Famotidine vs. omeprazole: a prospective randomized multicentre trial to determine efficacy in non-erosive gastro-oesophageal reflux disease.
    Fujiwara Y; Higuchi K; Nebiki H; Chono S; Uno H; Kitada K; Satoh H; Nakagawa K; Kobayashi K; Tominaga K; Watanabe T; Oshitani N; Arakawa T
    Aliment Pharmacol Ther; 2005 Jun; 21 Suppl 2():10-8. PubMed ID: 15943841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving health-related quality of life in gastro-oesophageal reflux disease.
    Shaw MJ; Crawley JA
    Drugs; 2003; 63(21):2307-16. PubMed ID: 14524732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lansoprazole in the treatment of gastro-oesophageal reflux disease in childhood.
    Franco MT; Salvia G; Terrin G; Spadaro R; De Rosa I; Iula VD; Cucchiara S
    Dig Liver Dis; 2000 Nov; 32(8):660-6. PubMed ID: 11142573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Night-time gastro-oesophageal reflux disease: prevalence, hazards, and management.
    Orr WC
    Eur J Gastroenterol Hepatol; 2005 Jan; 17(1):113-20. PubMed ID: 15647651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acid pump inhibitors. The treatment of gastroesophageal reflux.
    Hetzel D
    Aust Fam Physician; 1998 Jun; 27(6):487-91. PubMed ID: 9648315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How do we offer clinical relief to patients with gastro-oesophageal reflux disease?
    Galmiche JP
    Eur J Gastroenterol Hepatol; 2000 Jun; 12 Suppl 1():S3-6. PubMed ID: 10929891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Helicobacter pylori infection influences symptomatic response to anti-secretory therapy in patients with GORD--crossover comparative study with famotidine and low-dose lansoprazole.
    Adachi K; Hashimoto T; Komazawa Y; Mihara T; Furuta K; Fujishiro H; Ishihara S; Amano Y; Hattori S; Kinoshita Y
    Dig Liver Dis; 2005 Jul; 37(7):485-90. PubMed ID: 15975534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of an empirical trial of high-dose lansoprazole on symptom response of patients with non-cardiac chest pain--a randomized, double-blind, placebo-controlled, crossover trial.
    Bautista J; Fullerton H; Briseno M; Cui H; Fass R
    Aliment Pharmacol Ther; 2004 May; 19(10):1123-30. PubMed ID: 15142202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monitoring of omeprazole treatment in gastro-oesophageal reflux disease.
    Hendel J; Hendel L; Hage E; Hendel J; Aggestrup S; Nielsen OH
    Eur J Gastroenterol Hepatol; 1996 May; 8(5):417-20. PubMed ID: 8804867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.